Investing Profile

Roy Lobb

InvestorVC
Venture Partner at Advent Life Sciences
Photo of Roy Lobb, Venture Partner at Advent Life Sciences

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Oxford Network
96 CONNECTIONS
cb
Advent Life Sciences Venture Partner
$25K - $5.0M
$1M
director and cofounder Aleta Biotherapeutics2015 - Present
consultant & co-founder Avila Therapeutics2007 - 2012
Senior director Discovery Research Biogen1987 - 2001
University of Oxford DPhil Chemistry